The author is at the University of Western Ontario and the Robarts Research Institute, London, Ontario, N6G 2V4, Canada. mcfadden@robarts.ca
The tyrosine kinase inhibitor Gleevec, currently used to treat cancers such as chronic myeloid leukemia, can also function as an antiviral drug to treat poxvirus infections (pages 731−739).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
